Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Samual Ayaya"'
Autor:
Matthias Egger, Fatoumata Dicko, Dorita Avila, Manuel Koller, Kara Wools-Kaloustian, Kulkanya Chokephaibulkit, Huu Khanh Truong, Rohan Hazra, Cleophas Chimbetete, Mary-Ann Davies, Samual Ayaya, Kunjal Patel, Benjamin C. Chi, Valériane Leroy
Publikováno v:
Koller, Manuel; Patel, Kunjal; Chi, Benjamin H; Wools-Kaloustian, Kara; Dicko, Fatoumata; Chokephaibulkit, Kulkanya; Chimbetete, Cleophas; Avila, Dorita; Hazra, Rohan; Ayaya, Samual; Leroy, Valeriane; Truong, Huu Khanh; Egger, Matthias; Davies, Mary-Ann (2015). Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. Journal of acquired immune deficiency syndromes JAIDS, 68(1), pp. 62-72. Lippincott Williams & Wilkins 10.1097/QAI.0000000000000380
ResearcherID
ResearcherID
BACKGROUND The CD4 cell count or percent (CD4%) at the start of combination antiretroviral therapy (cART) is an important prognostic factor in children starting therapy and an important indicator of program performance. We describe trends and determi
Autor:
Samual Ayaya, Cleophas Chimbetete, Mary-Ann Davies, Rohan Hazra, Valériane Leroy, Kara Wools-Kaloustian, Matthias Egger, Kulkanya Chokephaibulkit, Kunjal Patel, Huu Khanh Trong, Manuel Koller, Benjamin H. Chi, Fatoumata Dicko
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Koller, Manuel; Patel, Kunjal; Chi, Benjamin H; Wools-Kaloustian, Kara; Dicko, Fatoumata; Chokephaibulkit, Kulkanya; Chimbetete, Cleophas; Hazra, Rohan; Ayaya, Samual; Leroy, Valeriane; Trong, Huu Khanh; Egger, Matthias; Davies, Mary-Ann (2015). Response to Doherty et al: Early initiation of antiretroviral therapy amongst young children: a long way to go. Journal of acquired immune deficiency syndromes JAIDS, 70(2), e71-e72. Lippincott Williams & Wilkins 10.1097/QAI.0000000000000773
Koller, Manuel; Patel, Kunjal; Chi, Benjamin H; Wools-Kaloustian, Kara; Dicko, Fatoumata; Chokephaibulkit, Kulkanya; Chimbetete, Cleophas; Hazra, Rohan; Ayaya, Samual; Leroy, Valeriane; Trong, Huu Khanh; Egger, Matthias; Davies, Mary-Ann (2015). Response to Doherty et al: Early initiation of antiretroviral therapy amongst young children: a long way to go. Journal of acquired immune deficiency syndromes JAIDS, 70(2), e71-e72. Lippincott Williams & Wilkins 10.1097/QAI.0000000000000773
The CD4 cell count or percent (CD4%) at the start of combination antiretroviral therapy (cART) is an important prognostic factor in children starting therapy and an important indicator of program performance. We describe trends and determinants of CD
Autor:
Michael L. Scanlon, Imke H. Bartelink, Edward A. Liechty, Samual Ayaya, Winstone M. Nyandiko, Terry F. Blaschke, Rada M. Savic, Naftali Busakhala, Rachel C. Vreeman
Publikováno v:
Vreeman, R C, Nyandiko, W M, Liechty, E A, Busakhala, N, Bartelink, I H, Savic, R M, Scanlon, M L, Ayaya, S O & Blaschke, T F 2014, ' Impact of adherence and anthropometric characteristics on nevirapine pharmacokinetics and exposure among HIV-infected Kenyan children ', Journal of Acquired Immune Deficiency Syndromes, vol. 67, no. 3, pp. 277-286 . https://doi.org/10.1097/QAI.0000000000000300
Journal of Acquired Immune Deficiency Syndromes, 67(3), 277-286
Journal of Acquired Immune Deficiency Syndromes, 67(3), 277-286
Background: There are insufficient data on pediatric antiretroviral therapy (ART) pharmacokinetics (PK), particularly for children in low- and middle-income countries. Methods: We conducted a prospective nevirapine (NVP) PK study among HIV-infected K